End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.33 CNY | +3.54% | +2.43% | -39.05% |
26/04 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
25/04 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
Chart calendar Walvax Biotechnology Co., Ltd.
Upcoming events on Walvax Biotechnology Co., Ltd.
Past events on Walvax Biotechnology Co., Ltd.
25/04/2024 | Q1 2024 Earnings Release |
19/04/2024 11:30 am | Annual General Meeting |
30/03/2024 | Q4 2023 Earnings Release |
26/10/2023 | Q3 2023 Earnings Release |
26/08/2023 | Q2 2023 Earnings Release |
21/08/2023 11:30 am | Extraordinary Shareholders Meeting |
25/04/2023 | Q1 2023 Earnings Release |
20/04/2023 11:30 am | Annual General Meeting |
30/03/2023 | Q4 2022 Earnings Release |
25/10/2022 | Q3 2022 Earnings Release |
13/10/2022 11:30 am | Extraordinary Shareholders Meeting |
26/08/2022 11:30 am | Extraordinary Shareholders Meeting |
11/08/2022 | Interim 2022 Earnings Release |
29/04/2022 | Q1 2022 Earnings Release |
12/04/2022 11:30 am | Annual General Meeting |
19/03/2022 | FY 2021 Earnings Release |
27/12/2021 | Extraordinary Shareholders Meeting |
16/11/2021 11:30 am | Extraordinary Shareholders Meeting |
29/10/2021 | Q3 2021 Earnings Release |
28/08/2021 | Interim 2021 Earnings Release |
Past dividends on Walvax Biotechnology Co., Ltd.
11/05/2023 | Annual 0.01 CNY |
26/04/2022 | Annual 0.027 CNY |
19/05/2021 | Final Payment 0.05 CNY |
30/09/2020 | Interim Payment 0.02 CNY |
23/07/2019 | Annual 0.03 CNY |
23/04/2015 | Annual 0.05 CNY |
30/05/2014 | Annual 0.05 CNY |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 1 121 1 037 8.12% | 2 939 3 686 -20.26% | 3 463 3 462 0.04% | 5 086 5 461 -6.86% | 4 114 4 083 0.76% | 4 132 |
EBITDA Million CNY | Released Forecast Spread | 0,00 0,00 - | 1 505 1 511 -0.41% | 851 1 090 -21.9% | 1 358 1 688 -19.51% | 920 1 332 -30.95% | 1 517 |
EBIT Million CNY | Released Forecast Spread | 233 242 -3.77% | 1 376 1 312 4.92% | 710 824 -13.82% | 1 099 1 309 -15.99% | 614 1 247 -50.75% | 1 203 |
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 229 242 -5.18% | 1 373 1 311 4.72% | 709 0,00 - | 0,00 0,00 - | 599 1 365 -56.12% | 1 642 |
Net income Million CNY | Released Forecast Spread | 142 210 -32.39% | 1 003 976 2.79% | 428 0,00 - | 729 770 -5.37% | 419 433 -3.07% | 781 |
EPS CNY | Released Forecast Spread | 0,09 0,14 -34.07% | 0,64 0,64 1.32% | 0,27 0,91 -70.12% | 0,45 0,48 -5.33% | 0,26 0,27 -2.93% | 0,49 |
Announcement Date | 06/02/20 | 25/03/21 | 18/03/22 | 29/03/23 | 29/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million CNY | Released Forecast Spread | 656 927 -29.27% | 1 692 1 885 -10.22% | 1 358 1 663 -18.33% | 1 380 1 755 -21.34% | 833 949 -12.23% | 1 334 2 132 -37.42% | 990 1 645 -39.78% | 956 925 3.35% | 600 812 -26.14% | 1 466 | 1 033 | 1 033 | 729 |
EBIT Million CNY | Released Forecast Spread | 92,7 286 -67.62% | 523 590 -11.27% | 213 491 -56.68% | 270 406 -33.35% | 214 112 92.02% | 418 548 -23.87% | 147 449 -67.24% | -165 333 -149.63% | 59,6 255 -76.61% | 513 | 302 | 265 | 104 |
EPS CNY | Released Forecast Spread | 0,02 0,12 -79.92% | 0,24 0,26 -8.5% | 0,08 0,19 -57.89% | 0,11 0,15 -26.67% | 0,11 0,04 168.5% | 0,17 0,19 -10.53% | 0,06 0,19 -67.74% | -0,09 -0,08 -12.5% | 0,01 0,11 -92% | 0,25 | 0,11 | 0,12 | 0,03 |
Announcement Date | 28/04/22 | 10/08/22 | 24/10/22 | 29/03/23 | 24/04/23 | 25/08/23 | 25/10/23 | 29/03/24 | 24/04/24 | - | - | - | - |
Past sector events for Walvax Biotechnology Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 300142 Stock
- Calendar Walvax Biotechnology Co., Ltd.